These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 6334621

  • 1. [Corticotropin-releasing factor concentrations in cerebrospinal fluid and its diurnal rhythm in patients with Cushing's disease].
    Yokoe T, Kuwayama A, Ichihara K, Yamamoto N, Kageyama N.
    Nihon Naibunpi Gakkai Zasshi; 1984 Aug 20; 60(8):964-70. PubMed ID: 6334621
    [Abstract] [Full Text] [Related]

  • 2. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications.
    Kling MA, Roy A, Doran AR, Calabrese JR, Rubinow DR, Whitfield HJ, May C, Post RM, Chrousos GP, Gold PW.
    J Clin Endocrinol Metab; 1991 Feb 20; 72(2):260-71. PubMed ID: 1846869
    [Abstract] [Full Text] [Related]

  • 3. Immunoreactive corticotropin-releasing factor concentrations in cerebrospinal fluid from patients with hypothalamic-pituitary-adrenal disorders.
    Tomori N, Suda T, Tozawa F, Demura H, Shizume K, Mouri T.
    J Clin Endocrinol Metab; 1983 Dec 20; 57(6):1305-7. PubMed ID: 6605358
    [Abstract] [Full Text] [Related]

  • 4. Somatomedin levels in cerebrospinal fluid from adults with pituitary disorders.
    Bäckström M, Hall K, Sara V.
    Acta Endocrinol (Copenh); 1984 Oct 20; 107(2):171-8. PubMed ID: 6388207
    [Abstract] [Full Text] [Related]

  • 5. The corticotropin-releasing hormone test in the diagnosis of ACTH-dependent Cushing's syndrome: a reappraisal.
    Pecori Giraldi F, Invitti C, Cavagnini F, Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-pituitary-adrenal axis.
    Clin Endocrinol (Oxf); 2001 May 20; 54(5):601-7. PubMed ID: 11380490
    [Abstract] [Full Text] [Related]

  • 6. Selective bilateral and simultaneous catheterization of the inferior petrosal sinus: CRF stimulates prolactin secretion from ACTH-producing microadenomas in Cushing's disease.
    Schulte HM, Allolio B, Günther RW, Benker G, Winkelmann W, Ohnhaus EE, Reinwein D.
    Clin Endocrinol (Oxf); 1988 Mar 20; 28(3):289-95. PubMed ID: 2844450
    [Abstract] [Full Text] [Related]

  • 7. Cerebrospinal fluid immunoreactive somatostatin concentrations in patients with Cushing's disease and major depression: relationship to indices of corticotropin-releasing hormone and cortisol secretion.
    Kling MA, Rubinow DR, Doran AR, Roy A, Davis CL, Calabrese JR, Nieman LK, Post RM, Chrousos GP, Gold PW.
    Neuroendocrinology; 1993 Jan 20; 57(1):79-88. PubMed ID: 8097579
    [Abstract] [Full Text] [Related]

  • 8. [Studies for clinical application of ovine corticotropin-releasing factor].
    Kubo M.
    Hokkaido Igaku Zasshi; 1985 Mar 20; 60(2):282-98. PubMed ID: 2987091
    [Abstract] [Full Text] [Related]

  • 9. Presence of immunoreactive corticotropin-releasing factor in human cerebrospinal fluid.
    Suda T, Tozawa F, Mouri T, Demura H, Shizume K.
    J Clin Endocrinol Metab; 1983 Jul 20; 57(1):225-6. PubMed ID: 6602142
    [Abstract] [Full Text] [Related]

  • 10. Circulating adrenomedullin is increased in patients with corticotropin-dependent Cushing's syndrome due to pituitary adenoma.
    Letizia C, Di Iorio R, De Toma G, Marinoni E, Cerci S, Celi M, Subioli S, D'Erasmo E.
    Metabolism; 2000 Jun 20; 49(6):760-3. PubMed ID: 10877203
    [Abstract] [Full Text] [Related]

  • 11. Effects of cyproheptadine, reserpine, and synthetic corticotropin-releasing factor on pituitary glands from patients with Cushing's disease.
    Suda T, Tozawa F, Mouri T, Sasaki A, Shibasaki T, Demura H, Shizume K.
    J Clin Endocrinol Metab; 1983 Jun 20; 56(6):1094-9. PubMed ID: 6302123
    [Abstract] [Full Text] [Related]

  • 12. ACTH response to desmopressin in a patient with acromegaly; expression of corticotropin-releasing factor, urocortins and vasopressin V1b receptor in GH-producing pituitary adenoma.
    Arihara Z, Sakurai K, Osaki Y, Fukazawa H, Yamada S, Inoshita N, Murakami O, Ohba K, Takahashi K.
    Endocr J; 2011 Jun 20; 58(12):1029-36. PubMed ID: 21908929
    [Abstract] [Full Text] [Related]

  • 13. Immunoreactive corticotropin-releasing factor in human plasma.
    Suda T, Tomori N, Yajima F, Sumitomo T, Nakagami Y, Ushiyama T, Demura H, Shizume K.
    J Clin Invest; 1985 Nov 20; 76(5):2026-9. PubMed ID: 2997301
    [Abstract] [Full Text] [Related]

  • 14. Corticotrophin releasing factor: responses in normal subjects and patients with disorders of the hypothalamus and pituitary.
    Lytras N, Grossman A, Perry L, Tomlin S, Wass JA, Coy DH, Schally AV, Rees LH, Besser GM.
    Clin Endocrinol (Oxf); 1984 Jan 20; 20(1):71-84. PubMed ID: 6319053
    [Abstract] [Full Text] [Related]

  • 15. Responsiveness of the hypophyseal-adrenocortical axis to corticotropin-releasing factor in pituitary-dependent Cushing's disease.
    Pieters GF, Hermus AR, Smals AG, Bartelink AK, Benraad TJ, Kloppenborg PW.
    J Clin Endocrinol Metab; 1983 Sep 20; 57(3):513-6. PubMed ID: 6308029
    [Abstract] [Full Text] [Related]

  • 16. CRF in the differential diagnosis of Cushing's syndrome: a comparison with the dexamethasone suppression test.
    Grossman AB, Howlett TA, Perry L, Coy DH, Savage MO, Lavender P, Rees LH, Besser GM.
    Clin Endocrinol (Oxf); 1988 Aug 20; 29(2):167-78. PubMed ID: 2854761
    [Abstract] [Full Text] [Related]

  • 17. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome.
    Chrousos GP, Schulte HM, Oldfield EH, Gold PW, Cutler GB, Loriaux DL.
    N Engl J Med; 1984 Mar 08; 310(10):622-6. PubMed ID: 6319991
    [Abstract] [Full Text] [Related]

  • 18. Plasma ACTH-response to the corticotropin releasing factor in patients with Cushing's disease. Comparison with the lysine-vasopressin test.
    Catania A, Cantalamessa L, Orsatti A, Mosca G, Minonzio F, Motta P, Reschini E, Zanussi C.
    Metabolism; 1984 May 08; 33(5):478-81. PubMed ID: 6325850
    [Abstract] [Full Text] [Related]

  • 19. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?
    Loli P, Boccardi E, Branca V, Bramerio M, Barberis M, Losa M, Terreni MT, Lodrini S, Pollo B, Vignati F.
    Clin Endocrinol (Oxf); 1998 Oct 08; 49(4):433-9. PubMed ID: 9876339
    [Abstract] [Full Text] [Related]

  • 20. Effects of synthetic corticotropin-releasing factor in normal individuals and in patients with hypothalamic-pituitary-adrenocortical disorders.
    Jørgensen H, Skare S, Frey H, Hanssen KF, Norman N.
    Acta Med Scand; 1985 Oct 08; 218(1):79-84. PubMed ID: 2996312
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.